High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy - Manubens A; Paiva B; Gutiérrez NC; Fernandez M; Calasanz MJ; Rosiñol L; Oriol A; Blanchard MJ; Carrillo E; Benavente C; Martínez-López J; Bargay J; et al. (Hemasphere, 2025)